News & Trends - Pharmaceuticals

PAIG to launch mental health and wellbeing program for Pharma member companies

Health Industry Hub | May 18, 2020 |
[Total: 1    Average: 5/5]

The COVID-19 pandemic is leading to increased levels of stress, worry and anxiety. The associated uncertainty, disruption to usual routines, the need for working from home and self-isolation is having a significant impact on wellbeing and mental health.

In an interview with Health Industry Hub, Pharma Australia Inclusion Group (PAIG) co-chairs Lee Davelaar, Strategic Policy Manager at Pfizer, and Fiona Sheppard, Diversity & Inclusion Leader ANZ at Johnson & Johnson, discussed plans to bring forward PAIG’s mental health and wellbeing focus to assist member companies and their employees. PAIG is a special interest group of Medicines Australia with a vision to strengthen diversity and inclusion in the workplace.

PAIG aims to play an important role in helping organisations navigate mental health conversations in addition to its focus on flexible working, mindfulness and resilience training. The holistic approach to wellbeing seeks to enhance employees’ positive connection to their workplace and build a sense of purpose to drive engagement and productivity. The four components of a holistic approach to wellbeing include physical, financial, social and psychological / emotional.

PAIG is partnering with Willis Towers Watson to deliver a novel mental health and wellbeing program to PAIG member companies.

Ms Sheppard said “COVID-19 has brought the mental health and wellbeing conversation to the forefront. It has opened the door for us to have a platform to have those conversations. With the delivery of this program we need to acknowledge that each of the member organisations is in a different place in their employee wellbeing journey. The new program format will enable us to deliver content to more people by tailoring it to their needs.”

Mr Davelaar explained that the PAIG program will incorporate six modules over a fortnight. It has been adapted from a face to face delivery to an online format in line with the current COVID-19 environment. The updated program is a combination of short online sessions, podcasts, videos, self-learning and small group discussions to diversify content delivery and maximise employee engagement. It will also better support the member organisation with respect to where they are in their mental health and wellbeing journey with their employees.

PAIG was founded by Kirsten O’Doherty, former Vice President & General Manager of AbbVie ANZ, Melissa McGregor, former Managing Director of Pfizer ANZ and Kathy Connell, Senior Director, New Ventures of Johnson and Johnson Innovation.

PAIG member companies include MSD, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Takeda, Merck, Janssen, Amgen, Roche, Astellas, BMS, Gilead, Biogen, Novo Nordisk, Novartis, Pfizer and AbbVie.

In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to encourage Pharma, Biotech and MedTech industry professionals to take action on mental health during COVID-19. LinkedIn post.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - COVID-19 wiping out hard-won gains by women in STEM

COVID-19 wiping out hard-won gains by women in STEM

Health Industry Hub | June 1, 2020 |

Hard-won gains for women’s advancement in the science, technology, engineering and maths (STEM) workforce are now at risk of a […]

More


News & Trends - Medical Technology

MedTech News - New agreement to end public hospitals' “harvesting” of privately insured patients

New agreement to end public hospital “harvesting” of privately insured patients

Health Industry Hub | June 1, 2020 |

MedTech News: The new National Health Reform Agreement has the potential to end the practice of public hospitals “harvesting” privately […]

More


News & Trends - Pharmaceuticals

Pharma News - GSK's targeted therapy for asthma gains PBS listing for self-administration delivery

GSK’s targeted therapy for asthma gains PBS listing for self-administration delivery

Health Industry Hub | June 1, 2020 |

Pharma News: From 1 June 2020, GSK Australia’s new pre-filled pen (autoinjector) for the self-administration of its targeted therapy for […]

More


News & Trends - Pharmaceuticals

Pharma News - Major changes to opioid PBS listings effective 1 June

Major changes to opioid PBS listings effective 1 June

Health Industry Hub | June 1, 2020 |

Commencing 1 June 2020, the Pharmaceutical Benefits Scheme (PBS) listings for opioid medicines will change including Tramal (tramadol) and Panadeine […]

More